Beranda › Kanker Rahim › North Carolina
Uji klinis Kanker Rahim di North Carolina
4 studi untuk Kanker Rahim mencari peserta di lokasi di North Carolina.
Teks studi resmi (Bahasa Inggris)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Charlotte
- Research Site, Charlotte
- Research Site, Winston-Salem
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Greenville
- Research Site, Pinehurst
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
- Duke Cancer Center, Durham
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Wanita · Diperbarui 6 Mar 2026 · NCT05977621Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.